Analyst Ratings for Pacira Pharmaceuticals (PCRX) [Sells]

PCRX Rating Summary

PCRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PCRX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $78.54 (+26.5%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/26/2017 Janney N/A Downgrade Sell
(Neutral)
N/A
(N/A)
31.85
(62.09)
94.95% Details
Like PCRX Ratings? Also take a look at HRTX

PCRX Ratings News